Quest Diagnostics Inc(DGX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 24.19 | EPS (ttm) | 10.04 | Insider Own | 0.48% | Shs Outstand | 110.0M | Perf Week | 3.42% |
| Market Cap | 26.81B | Forward P/E | 20.28 | EPS next Y | 6.01% | Insider Trans | -9% | Shs Float | 109.8M | Perf Month | 2.81% |
| Enterprise Value | 32.70B | PEG | 2.05 | EPS next Q | 2.68 | Inst Own | 97.8% | Short Float | 3.11% | Perf Quarter | 2.97% |
| Income | 1.13B | P/S | 2.26 | EPS this Y | 14.74% | Inst Trans | 0.61% | Short Ratio | 3.37 | Perf Half Y | 23.56% |
| Sales | 11.84B | P/B | 3.5 | EPS next 5Y | 9.89% | ROA | 6.73% | Short Interest | 3.42M | Perf YTD | 40% |
| Book/sh | 69.38 | P/C | 33.64 | EPS past 3/5Y | 3.08% -3.64% | ROE | 15.11% | 52W High | -2.37% ($248.84) | Perf Year | 33.36% |
| Cash/sh | 7.22 | P/FCF | 19.5 | Sales past 3/5Y | 3.74% 3.18% | ROIC | 8.2% | 52W Low | 41.93% ($171.18) | Perf 3Y | 85.09% |
| Dividend Est. | $3.33 (1.37%) | EV/EBITDA | 14.02 | EPS Y/Y TTM | 17.93% | Gross Margin | 31.91% | Volatility(W/M) | 4.21% 2.52% | Perf 5Y | 66.98% |
| Dividend TTM | 3.38 | EV/Sales | 2.76 | Sales Y/Y TTM | 9.13% | Oper. Margin | 14.76% | ATR (14) | 6.39 | Perf 10Y | 203.12% |
| Dividend Ex-Date | 2026/10/6 | Quick Ratio | 1.58 | EPS Q/Q | 28.72% | Profit Margin | 9.5% | RSI (14) | 60.26 | Recom | 2.15 |
| Dividend Gr. 3/5Y | 6.62% 7.39% | Current Ratio | 1.7 | Sales Q/Q | 9.98% | SMA20 | 3.63% ($234.44) | Beta | 0.55 | Target Price | $255.57 |
| Payout | 36.6% | Debt/Eq | 0.82 | Earnings | 2026/10/22 | SMA50 | 2.18% ($237.77) | Rel Volume | 0.95 | Prev Close | $241.89 |
| Employees | 57000 | LT Debt/Eq | 0.8 | EPS/Sales Surpr. | 4.35% 1.47% | SMA200 | 15.27% ($210.77) | Avg Volume(3M) | 1.01M | Price | $242.95 |
| IPO | 1996/12/17 | Option/Short | Yes/Yes | Trades | 17318 | Volume | 959,924 | Change | 0.44% |
🔬 Quest Diagnostics (DGX) is a leading medical diagnostics company that reliably delivers comprehensive, high-quality clinical diagnostic information services and advanced precision testing solutions for early disease detection to a large number of patients and major healthcare institutions across the United States.
Over the past 1 year, on the higher side
2% below its 1-year high.
Traded about as much as usual. That is 95% of its average volume.
DGX makes money exceptionally well
Of every $100 in sales, $14.76 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +14.7% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $2,419. Peers typically go for $3,683. Compared with its own 5-year average, it is 21% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +67.0%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.37% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 97.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #10 of 44 in the industry
Based on market cap of $27B.
MTD#9 Mettler-Toledo International Inc $33B PER 37.6 DGX#10 Quest Diagnostics Inc $27B PER 24.2 
LH#11 Labcorp Holdings Inc $27B PER 27.3 
GH#12 Guardant Health Inc $23B PER - 
MEDP#13 Medpace Holdings Inc $19B PER 37.5 
FAQ
What kind of company is DGX?
DGX belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of DGX?
The market cap of DGX is approximately $26.8B, ranking 496 within its sector.
Does DGX pay dividends?
DGX has a dividend yield of approximately 1.37%, with an annual dividend of $3.33.
What is the P/E ratio of DGX?
DGX has a P/E ratio of approximately 24.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for DGX?
DGX has recorded a 52-week high of $248.84 and a low of $171.18.
